{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T22:46:53Z","timestamp":1749682013450},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.vaccine.2004.06.052","type":"journal-article","created":{"date-parts":[[2004,8,26]],"date-time":"2004-08-26T23:32:12Z","timestamp":1093563132000},"page":"802-806","source":"Crossref","is-referenced-by-count":28,"title":["Dose response of CRM197 and tetanus toxoid-conjugated Haemophilus influenzae type b vaccines"],"prefix":"10.1016","volume":"23","author":[{"given":"Robin E.","family":"Huebner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Nicol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalia","family":"Mothupi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"K\u00e4yhty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nontombi","family":"Mbelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Khomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith P.","family":"Klugman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2004.06.052_bib1","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(96)09267-7","article-title":"Randomised trial of Haemophilus influenzae type b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infants","volume":"349","author":"Mulholland","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2004.06.052_bib2","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1542\/peds.60.5.730","article-title":"Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland","volume":"60","author":"Peltola","year":"1977","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2004.06.052_bib3","series-title":"Vaccines","first-page":"183","article-title":"Haemophilus influenzae vaccines","author":"Ward","year":"1999"},{"key":"10.1016\/j.vaccine.2004.06.052_bib4","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/infdis\/161.6.1210","article-title":"The epidemiology of Haemophilus influenzae meningitis in children under 5 years of age in Gambia, West Africa","volume":"161","author":"Bijlmer","year":"1990","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2004.06.052_bib5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00006454-198906000-00002","article-title":"Epidemiology of invasive Haemophilus influenzae type b disease among children in Finland before vaccination with Haemophilus influenzae type b conjugate vaccine","volume":"8","author":"Takala","year":"1989","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2004.06.052_bib6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00006454-200202000-00010","article-title":"Haemophilus influenzae type b conjugate vaccine diluted tenfold in diphtheria\u2013tetanus\u2013whole cell pertussis vaccine: a randomized trial","volume":"21","author":"Nicol","year":"2002","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2004.06.052_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0022-1759(90)90264-V","article-title":"An ELISA employing a Haemophilus influenzae type b oligosaccharide:human serum albumin conjugate correlates with the radioantigen binding assay","volume":"135","author":"Phipps","year":"1990","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.vaccine.2004.06.052_bib8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/infdis\/155.1.100","article-title":"Immunogenicity in infants of a vaccine composed of Haemophilus influenzae type b capsular polysaccharide mixed with DPT or conjugated to diphtheria toxoid","volume":"155","author":"K\u00e4yhty","year":"1987","journal-title":"J. infect. Dis."},{"key":"10.1016\/j.vaccine.2004.06.052_bib9","unstructured":"Dean AG, Dean JA, Coulombier D, et al. EpiInfo. version 6: a Word Processing, Database and Statistics Program for Epidemiology on Microcomputers. Atlanta, GA, USA: Centers for Disease Control and Prevention, 1994."},{"key":"10.1016\/j.vaccine.2004.06.052_bib10","unstructured":"JMP\u00ae Statistical Discovery Software. Version 4. SAS Institute, Inc. Cary, NC. 2000."},{"key":"10.1016\/j.vaccine.2004.06.052_bib11","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4269\/ajtmh.2000.62.485","article-title":"Randomized trial of the immunogenicity of fractional dose regimens of PRP-T Haemophilus influenzae type b conjugate vaccine","volume":"62","author":"Fernandez","year":"2000","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.vaccine.2004.06.052_bib12","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0140-6736(97)07456-4","article-title":"Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens","volume":"351","author":"Lagos","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2004.06.052_bib13","unstructured":"Centers for Disease Control Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children: United States 1998\u20132000. MMWR 2002;51:234\u201337."},{"key":"10.1016\/j.vaccine.2004.06.052_bib14","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0140-6736(99)03010-X","article-title":"Haemophilus influenzae type b meningitis in The Gambia after introduction of a conjugate vaccine","volume":"354","author":"Adegbola","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2004.06.052_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00006454-200204000-00011","article-title":"Reduced effectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection","volume":"21","author":"Madhi","year":"2002","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.vaccine.2004.06.052_bib16","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1086\/315870","article-title":"Prevention of Haemophilus influenzae type b colonization by vaccination: correlation with serum anti-capsular IgG concentration","volume":"182","author":"Fernandez","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2004.06.052_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/(SICI)1099-1050(200001)9:1<19::AID-HEC487>3.0.CO;2-C","article-title":"Policy analysis of the use of hepatitis B, Haemophilus influenzae type b, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules","volume":"9","author":"Miller","year":"2000","journal-title":"Health Econ."},{"key":"10.1016\/j.vaccine.2004.06.052_bib18","doi-asserted-by":"crossref","unstructured":"Watt JP, Levine OS, Santosham M. Global reduction of Hib disease: What are the next steps? In: Proceedings of the Meeting, Scottsdale, Arizona, September 22\u201325, 2002. J Pediatr 2003;143:S163\u201387.","DOI":"10.1067\/S0022-3476(03)00576-6"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04005778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04005778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T07:16:57Z","timestamp":1682752617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04005778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0264410X04005778"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.06.052","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}